Story

Test for Nose Ointment As a COVID Therapy

Turn Therapeutics’ Hexagen gets in FDA approval line.

After nearly a year of correspondence with the U.S. Food and Drug Administration, Turn Therapeutics in Calabasas finally has its first human safety and efficacy trial lined up for a COVID-19 therapy.

Story

Calabasas Biotech to Test COVID Nose Ointment

Calabasas biotech Turn Therapeutics has announced it received authorization to start its first human safety and efficacy trial for a COVID-19 therapy.

Story

FDA Approves Ellume’s At-Home COVID-19 Test

The U.S. Food and Drug Administration has approved the first at-home COVID-19 test, developed by a biotech company with ties to the Valley region.

Tease photo
Story

First Home COVID Test In Valencia

Ellume’s $30 kit secures approval from the FDA.

Digital diagnostics company Ellume Inc., an Australian company with U.S. operations in Valencia, developed the first at-home COVID-19 test approved by the U.S. Food and Drug Administration.

Story

AROUND THE VALLEYS

AROUND THE VALLEYS

Story

Why Are We Waiting Like This?

‘I feel like we are all captive actors in the absurdist play “Waiting for Godot.” We are illogically sitting around, waiting for a vaccine to arrive. But a vaccine may be months away or even longer, and there is no assurance that it will be quickly deployable or even very effective.’

Story

Stein Mart Hires Great American Group for Liquidation

Great American Group in Woodland Hills is one of five liquidation companies managing the going-out-of-business sales for discount department store chain Stein Mart.

Story

State Small Business Fund Opens for Grant Applications

The state of California’s $500 million Small Business COVID-19 Relief Grant Program has opened its first round of applications

Story

CSUN’s Nazarian College Expands With Business Analytics Degree

Starting in fall 2021 semester, California State University – Northridge’s Nazarian College of Business and Economics will offer a bachelor’s degree in business analytics.

Story

Amgen Drug Among Those in Trial for COVID

Thousand Oaks-based biopharma giant Amgen Inc., which is part of the COVID R&D Alliance consortium of companies, will participate in the initiative’s first COVID-19 patient clinical trial. An Amgen drug is among those to be tested.

Story

COVID Caregiver

PROFILE: Bob Beitcher has guided the MPTF campus in Woodland Hills through ‘an intense year’ battling the coronavirus.

Bob Beitcher has led the Motion Picture & Television Fund’s Wasserman Campus in Woodland Hills for more than 10 years, and prior that was a major executive at multiple companies in the entertainment industry, including Panavision and Jim Henson Productions. He considers MPTF residents close friends, and has made it his mission to keep them as safe as possible, and their families well informed during the pandemic. Despite best efforts, eight residents and two staff members were lost to the virus.

Story

Ventura Lab Hosts Biome Conference

Malibu Microbiome Meeting followed with live Q&A.

Progenabiome in Ventura shared its Malibu Microbiome Meeting earlier this month,

Story

Valley Firm Develops COVID Test for Transplant Patients

One Lambda, a West Hills subsidiary of Thermo Fisher Scientific of Massachusetts, has developed a new COVID-19 test specifically for organ transplant candidates and recipients.

Story

Dine Brands’ Appetite for Growth Still Strong

RESTAURANTS: Analysts upbeat despite $135 million quarterly loss.

Analysts, executives upbeat about future prospects of Dine Brands Global Inc.

Story

Black ENTREPRENEURS MONTH: Laurent ‘Lou’ Correa  Lou, the French on the Block

4007 W. Riverside Dr., Burbank  Business: French bakery (747) 241-8205 • Website: Louthefrenchontheblock.com

Story

Recovery Blueprint

HEALTH CARE: Abbott Labs showcases back-to-work system, testing 1,000 employees a week.

HEALTH CARE: Abbott Labs showcases back-to-work system, testing 1,000 employees a week.

Story

Amgen’s Otezla Chosen For COVID-19 Study

Psoriasis drug to treat respiratory symptoms in test.

Psoriasis drug from Amgen Inc. chosen for COVID-19 study.

Story

Hey, Can We Just Start Over?

I cannot take this anymore. Month after month and year after year, I am saying everything I have said before. Yet, the more we say, the less elected officials hear.

Story

Looking to 2021 and Our Recovery

The holidays are here, which means 2020 is coming to an end. Under normal circumstances, a new year would represent new beginnings and new opportunities, but as we prepare to welcome the new year, the hard truth is that many of the issues and challenges we have faced throughout 2020 will remain with us in 2021.

Story

Elderly Homes Find Solutions Against Infection

LIST: Testing proves crucial to contain deadly virus.

Amid a pandemic that is disproportionately dangerous for older populations, the Motion Picture Television Fund’s Wasserman campus in Woodland Hills has achieved something remarkable.

Previous